Corneal Perforation Two Years After Mitomycin Intravascular Chemoembolization

Trakanta Wannapanich1, Raven Diacou, Vishal Jhanji

  • 1Department of Ophthalmology (T.W.), Center of Excellence for Cornea and Stem Cell Transplantation, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Department of Ophthalmology (T.W.), Excellence Center for Cornea and Stem Cell Transplantation, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand; and Department of Ophthalmology (R.D., V.J.), UPMC Vision Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Eye & Contact Lens
|May 29, 2026
PubMed

Insights

A rare case of delayed corneal perforation occurred two years after Mitomycin intravascular chemoembolization (MICE) for corneal neovascularization. This highlights the need for long-term monitoring after MICE, especially in vulnerable corneas.

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Regenerative Medicine

Background:

  • Corneal neovascularization (NV) poses a significant threat to vision.
  • Mitomycin intravascular chemoembolization (MICE) has emerged as a promising treatment for corneal NV.
  • Early outcomes of MICE are encouraging, but long-term complications require investigation.

Purpose of the Study:

  • To report a case of delayed corneal perforation following MICE.
  • To discuss potential mechanisms and implications of this rare complication.
  • To emphasize the importance of long-term surveillance after MICE.

Main Methods:

  • A case report of a 65-year-old male patient who underwent MICE for corneal NV.
  • Detailed clinical examination, including visual acuity and Seidel test.
  • Management of corneal perforation with corneal gluing and therapeutic patch graft.

Main Results:

  • A focal, Seidel-positive corneal perforation occurred two years post-MICE near the graft-host junction.
  • The perforation site was adjacent to previous corneal NV and lipid deposition.
  • Despite failed gluing attempts, a therapeutic patch graft led to improved visual acuity and a stable anterior chamber.

Conclusions:

  • This case suggests a potential for delayed stromal weakening after MICE in structurally compromised corneas.
  • Long-term surveillance is crucial for patients treated with MICE, particularly those with pre-existing corneal vulnerabilities.
  • Further research is needed to establish causality and elucidate the mechanisms of delayed stromal weakening post-MICE.